HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Policy

IRA, state PBM reform, Medicare, and regulatory action

Regulation of AI in Prior Authorization and Claims Review: A Look at Federal and State Consumer Protections
PolicyKFF Health News ↗
Amid the growing use of artificial intelligence (AI) in the claims review cycle, this brief discusses the type…
May 6, 2026
SCOTUS temporarily restores online access to abortion pill after appeals court ruling
PolicyFiercePharma ↗
The U.S. Supreme Court has temporarily reinstated online access to the abortion pill mifepristone after a fede…
May 6, 2026
STAT+: A new attack on AMA’s billing codes
PolicySTAT News ↗
A key GOP lawmaker is broadening the party's efforts to combat health care fraud.…
May 5, 2026
What’s at stake in Amgen’s showdown with the FDA?
PolicyPharmaVoice ↗
The agency accused Amgen of manipulating data for its fast-growing drug Tavneos and wants it pulled from the m…
May 5, 2026
CMS’s 2027 Medicare Advantage Rule Trades Transparency for Flexibility
PolicyBriefing
The final rule adds disclosure requirements for SSBCI benefits but eases prior consumer protection measures ar…
May 5, 2026
Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies
PolicySTAT News ↗
The Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that ha…
May 4, 2026
← Newer Page 8 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.